Support for rare disease innovation hub

Active Definitive Contract Awarded

Contract number
75F40126C00223
Awardee
Awarding agency
Obligated
$498,100

Award facts

Contract value 34% obligated
  • $498,100.00 Current, with exercised options
  • $1,478,036.00 Potential, with all options
Completion date 2% complete
  • Current, with exercised options
  • Potential, with all options
Contracting staff
NAICS code
541512 Computer Systems Design Services
PSC
DA10 It And Telecom - Business Application/Application Development Software As A Service
Set-aside
8(a) Sole Source
Competition
Not Available for Competition · 1 offer Only One Source
Pricing
Labor Hours
Place of performance
Silver Spring, MD 20993, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI ·

The Food and Drug Administration awarded a definitive contract to Lanevis, L.l.c for support of a Rare Disease Innovation Hub on September 30, 2026, under an 8(a) sole-source set-aside with a ceiling value of $1,478,036.

Lanevis is an 8(a) program participant and minority-owned small business. Work is performed at the FDA's Silver Spring, Maryland location. The contract runs on a labor-hours pricing model through March 26, 2029.

Quick answers

Who was awarded contract 75F40126C00223?

75F40126C00223 was awarded to Lanevis, L.l.c by Food and Drug Administration (Department of Health and Human Services) on September 30, 2026.

How much is contract 75F40126C00223 worth?

The government has obligated $498,100 on 75F40126C00223. Its potential value, with all options, is $1,478,036.

Was contract 75F40126C00223 competed?

The extent of competition for 75F40126C00223 was not available for competition. The government received 1 offer. It was set aside: 8(a) Sole Source.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login